P35991
Gene name |
Btk (Bpk) |
Protein name |
Tyrosine-protein kinase BTK |
Names |
EC 2.7.10.2 , Agammaglobulinemia tyrosine kinase , ATK , B-cell progenitor kinase , BPK , Bruton tyrosine kinase , Kinase EMB |
Species |
Mus musculus (Mouse) |
KEGG Pathway |
mmu:12229 |
EC number |
2.7.10.2: Protein-tyrosine kinases |
Protein Class |
TYROSINE-PROTEIN KINASE (PTHR24418) |

Descriptions
Bruton’s tyrosine kinase (BTK) is a non-receptor tyrosine kinase belonging to the TEC family, and is expressed primarily in B cells and myeloid cells, where it functions downstream of receptors including the B-cell receptor, Fc receptors, and toll-like receptors. BTK is autoinhibited by its SH3 and SH2 domains, forming a compact autoinhibitory conformation on the distal surface of the kinase domain. Additionally, there exists another autoinhibitory interface on the activation loop face of the kinase domain, which is occupied by the Pleckstrin homology and Tec homology (PHTH) domain. B-cell receptor engagement lead to BTK activation (via phosphorylation on Y551 in the activation loop), which results in the direct phosphorylation and activation of phospholipase C gamma 2 triggering calcium flux and subsequent regulation of gene transcription.
Autoinhibitory domains (AIDs)
Target domain |
397-652 (Protein kinase domain) |
Relief mechanism |
PTM |
Assay |
Structural analysis |
Target domain |
397-652 (Protein kinase domain) |
Relief mechanism |
PTM |
Assay |
Structural analysis |
Accessory elements
538-562 (Activation loop from InterPro)
Target domain |
397-652 (Protein kinase domain) |
Relief mechanism |
|
Assay |
|
Autoinhibited structure

Activated structure

8 structures for P35991
32 variants for P35991
Variant ID(s) | Position | Change | Description | Diseaes Association | Provenance |
---|---|---|---|---|---|
rs3389541818 | 25 | F>L | No | EVA | |
28 | R>C | XID; prevents interaction with ARID3A [UniProt] | No | ||
rs3389573169 | 36 | K>Q | No | EVA | |
rs3411955871 | 44 | F>SFGKLTPRSKSYS* | No | EVA | |
rs3389584353 | 91 | Q>* | No | EVA | |
rs3389587595 | 138 | L>Q | No | EVA | |
rs3389568336 | 218 | K>M | No | EVA | |
rs3389576101 | 227 | P>L | No | EVA | |
rs3389541792 | 262 | G>R | No | EVA | |
rs3389576158 | 277 | E>K | No | EVA | |
rs3411996247 | 290 | Q>H | No | EVA | |
rs3411177996 | 308 | D>V | No | EVA | |
rs3412197297 | 308 | D>Y | No | EVA | |
rs3412064298 | 311 | K>* | No | EVA | |
rs3410567339 | 311 | K>I | No | EVA | |
rs3412191238 | 311 | K>N | No | EVA | |
rs3412282049 | 334 | Y>F | No | EVA | |
rs3389573118 | 341 | Q>* | No | EVA | |
rs3411996267 | 344 | Y>* | No | EVA | |
rs3389573103 | 346 | L>M | No | EVA | |
rs263268603 | 353 | S>N | No | EVA | |
rs3389573164 | 375 | Y>* | No | EVA | |
rs3409324223 | 405 | L>* | No | EVA | |
rs3412092431 | 405 | L>M | No | EVA | |
rs3412197316 | 466 | K>I | No | EVA | |
rs3412092432 | 469 | P>T | No | EVA | |
rs3411616507 | 470 | I>S | No | EVA | |
rs3389541786 | 471 | F>S | No | EVA | |
rs3389587714 | 524 | A>V | No | EVA | |
rs3389541846 | 553 | S>N | No | EVA | |
rs229428789 | 580 | I>V | No | EVA | |
rs3389531712 | 633 | C>W | No | EVA |
No associated diseases with P35991
4 regional properties for P35991
Type | Name | Position | InterPro Accession |
---|---|---|---|
domain | Protein kinase domain | 14 - 272 | IPR000719 |
active_site | Serine/threonine-protein kinase, active site | 132 - 144 | IPR008271 |
domain | Calcium/calmodulin-dependent protein kinase II, association-domain | 380 - 507 | IPR013543 |
binding_site | Protein kinase, ATP binding site | 20 - 43 | IPR017441 |
Functions
Description | ||
---|---|---|
EC Number | 2.7.10.2 | Protein-tyrosine kinases |
Subcellular Localization |
|
|
PANTHER Family | PTHR24418 | TYROSINE-PROTEIN KINASE |
PANTHER Subfamily | PTHR24418:SF92 | TYROSINE-PROTEIN KINASE BTK |
PANTHER Protein Class | non-receptor tyrosine protein kinase | |
PANTHER Pathway Category |
B cell activation Btk |
7 GO annotations of cellular component
Name | Definition |
---|---|
cytoplasm | The contents of a cell excluding the plasma membrane and nucleus, but including other subcellular structures. |
cytoplasmic vesicle | A vesicle found in the cytoplasm of a cell. |
cytosol | The part of the cytoplasm that does not contain organelles but which does contain other particulate matter, such as protein complexes. |
membrane raft | Any of the small (10-200 nm), heterogeneous, highly dynamic, sterol- and sphingolipid-enriched membrane domains that compartmentalize cellular processes. Small rafts can sometimes be stabilized to form larger platforms through protein-protein and protein-lipid interactions. |
nucleus | A membrane-bounded organelle of eukaryotic cells in which chromosomes are housed and replicated. In most cells, the nucleus contains all of the cell's chromosomes except the organellar chromosomes, and is the site of RNA synthesis and processing. In some species, or in specialized cell types, RNA metabolism or DNA replication may be absent. |
perinuclear region of cytoplasm | Cytoplasm situated near, or occurring around, the nucleus. |
plasma membrane | The membrane surrounding a cell that separates the cell from its external environment. It consists of a phospholipid bilayer and associated proteins. |
8 GO annotations of molecular function
Name | Definition |
---|---|
ATP binding | Binding to ATP, adenosine 5'-triphosphate, a universally important coenzyme and enzyme regulator. |
identical protein binding | Binding to an identical protein or proteins. |
metal ion binding | Binding to a metal ion. |
non-membrane spanning protein tyrosine kinase activity | Catalysis of the reaction |
phosphatidylinositol-3,4,5-trisphosphate binding | Binding to phosphatidylinositol-3,4,5-trisphosphate, a derivative of phosphatidylinositol in which the inositol ring is phosphorylated at the 3', 4' and 5' positions. |
phospholipase activator activity | Binds to and increases the activity of a phospholipase, an enzyme that catalyzes of the hydrolysis of a glycerophospholipid. |
phospholipase binding | Binding to a phospholipase. |
protein tyrosine kinase activity | Catalysis of the reaction |
34 GO annotations of biological process
Name | Definition |
---|---|
adaptive immune response | An immune response mediated by cells expressing specific receptors for antigens produced through a somatic diversification process, and allowing for an enhanced secondary response to subsequent exposures to the same antigen (immunological memory). |
apoptotic process | A programmed cell death process which begins when a cell receives an internal (e.g. DNA damage) or external signal (e.g. an extracellular death ligand), and proceeds through a series of biochemical events (signaling pathway phase) which trigger an execution phase. The execution phase is the last step of an apoptotic process, and is typically characterized by rounding-up of the cell, retraction of pseudopodes, reduction of cellular volume (pyknosis), chromatin condensation, nuclear fragmentation (karyorrhexis), plasma membrane blebbing and fragmentation of the cell into apoptotic bodies. When the execution phase is completed, the cell has died. |
B cell affinity maturation | The process in which B cells produce antibodies with increased antigen affinity. This is accomplished by somatic hypermutation and selection for B cells which produce higher affinity antibodies to antigen. |
B cell receptor signaling pathway | The series of molecular signals initiated by the cross-linking of an antigen receptor on a B cell. |
cell maturation | The cellular developmental process, independent of morphogenetic (shape) change, that is required for a specific cell to attain its fully functional state. |
cellular response to interleukin-7 | Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of an interleukin-7 stimulus. |
cellular response to molecule of fungal origin | Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a stimulus by molecules of fungal origin such as chito-octamer oligosaccharide. |
cellular response to reactive oxygen species | Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a reactive oxygen species stimulus. Reactive oxygen species include singlet oxygen, superoxide, and oxygen free radicals. |
eosinophil homeostasis | The process of regulating the proliferation and elimination of eosinophils such that the total number of eosinophils within a whole or part of an organism is stable over time in the absence of an outside stimulus. |
histamine secretion by mast cell | The regulated release of histamine by a mast cell or group of mast cells. |
innate immune response | Innate immune responses are defense responses mediated by germline encoded components that directly recognize components of potential pathogens. |
intracellular signal transduction | The process in which a signal is passed on to downstream components within the cell, which become activated themselves to further propagate the signal and finally trigger a change in the function or state of the cell. |
monocyte proliferation | The expansion of a monocyte population by cell division. |
negative regulation of B cell activation | Any process that stops, prevents, or reduces the frequency, rate or extent of B cell activation. |
negative regulation of B cell proliferation | Any process that stops, prevents or reduces the rate or extent of B cell proliferation. |
negative regulation of cytokine production | Any process that stops, prevents, or reduces the rate of production of a cytokine. |
negative regulation of interleukin-10 production | Any process that stops, prevents, or reduces the frequency, rate, or extent of interleukin-10 production. |
negative regulation of leukocyte proliferation | Any process that stops, prevents, or reduces the frequency, rate or extent of leukocyte proliferation. |
neutrophil homeostasis | The process of regulating the proliferation and elimination of neutrophils such that the total number of neutrophils within a whole or part of an organism is stable over time in the absence of an outside stimulus. |
phosphorylation | The process of introducing a phosphate group into a molecule, usually with the formation of a phosphoric ester, a phosphoric anhydride or a phosphoric amide. |
positive regulation of B cell proliferation | Any process that activates or increases the rate or extent of B cell proliferation. |
positive regulation of immunoglobulin production | Any process that activates or increases the frequency, rate, or extent of immunoglobulin production. |
positive regulation of interleukin-17A production | Any process that activates or increases the frequency, rate or extent of interleukin-17A production. |
positive regulation of interleukin-6 production | Any process that activates or increases the frequency, rate, or extent of interleukin-6 production. |
positive regulation of NLRP3 inflammasome complex assembly | Any process that activates or increases the frequency, rate or extent of NLRP3 inflammasome complex assembly. |
positive regulation of phagocytosis | Any process that activates or increases the frequency, rate or extent of phagocytosis. |
positive regulation of synoviocyte proliferation | Any process that activates or increases the frequency, rate or extent of synoviocyte proliferation. |
positive regulation of tumor necrosis factor production | Any process that activates or increases the frequency, rate or extent of tumor necrosis factor production. |
positive regulation of type I hypersensitivity | Any process that activates or increases the frequency, rate or extent of type I hypersensitivity, a type of inflammatory response. |
positive regulation of type III hypersensitivity | Any process that activates or increases the frequency, rate or extent of type III hypersensitivity, a type of inflammatory response. |
proteoglycan catabolic process | The chemical reactions and pathways resulting in the breakdown of proteoglycans, any glycoprotein in which the carbohydrate units are glycosaminoglycans. |
response to lipopolysaccharide | Any process that results in a change in state or activity of an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a lipopolysaccharide stimulus; lipopolysaccharide is a major component of the cell wall of gram-negative bacteria. |
response to organic substance | Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of an organic substance stimulus. |
T cell receptor signaling pathway | The series of molecular signals initiated by the cross-linking of an antigen receptor on a T cell. |
86 homologous proteins in AiPD
UniProt AC | Gene Name | Protein Name | Species | Evidence Code |
---|---|---|---|---|
A0JNB0 | FYN | Tyrosine-protein kinase Fyn | Bos taurus (Bovine) | SS |
Q0VBZ0 | CSK | Tyrosine-protein kinase CSK | Bos taurus (Bovine) | SS |
Q3ZC95 | BTK | Tyrosine-protein kinase | Bos taurus (Bovine) | EV SS |
P42683 | LCK | Proto-oncogene tyrosine-protein kinase LCK | Gallus gallus (Chicken) | SS |
P41239 | CSK | Tyrosine-protein kinase CSK | Gallus gallus (Chicken) | SS |
P00523 | SRC | Proto-oncogene tyrosine-protein kinase Src | Gallus gallus (Chicken) | EV |
Q02977 | YRK | Proto-oncogene tyrosine-protein kinase Yrk | Gallus gallus (Chicken) | SS |
P09324 | YES1 | Tyrosine-protein kinase Yes | Gallus gallus (Chicken) | SS |
Q05876 | FYN | Tyrosine-protein kinase Fyn | Gallus gallus (Chicken) | SS |
Q75R65 | JAK2 | Tyrosine-protein kinase JAK2 | Gallus gallus (Chicken) | SS |
Q8JH64 | BTK | Tyrosine-protein kinase BTK | Gallus gallus (Chicken) | SS |
Q24592 | hop | Tyrosine-protein kinase hopscotch | Drosophila melanogaster (Fruit fly) | PR |
Q9V9J3 | Src42A | Tyrosine-protein kinase Src42A | Drosophila melanogaster (Fruit fly) | SS |
P00528 | Src64B | Tyrosine-protein kinase Src64B | Drosophila melanogaster (Fruit fly) | SS |
P08630 | Btk | Tyrosine-protein kinase Btk | Drosophila melanogaster (Fruit fly) | SS |
P41240 | CSK | Tyrosine-protein kinase CSK | Homo sapiens (Human) | SS |
P51451 | BLK | Tyrosine-protein kinase Blk | Homo sapiens (Human) | SS |
P06239 | LCK | Tyrosine-protein kinase Lck | Homo sapiens (Human) | EV |
P23458 | JAK1 | Tyrosine-protein kinase JAK1 | Homo sapiens (Human) | SS |
P06241 | FYN | Tyrosine-protein kinase Fyn | Homo sapiens (Human) | SS |
P51813 | BMX | Cytoplasmic tyrosine-protein kinase BMX | Homo sapiens (Human) | SS |
P12931 | SRC | Proto-oncogene tyrosine-protein kinase Src | Homo sapiens (Human) | EV |
P09769 | FGR | Tyrosine-protein kinase Fgr | Homo sapiens (Human) | SS |
P42680 | TEC | Tyrosine-protein kinase Tec | Homo sapiens (Human) | SS |
O60674 | JAK2 | Tyrosine-protein kinase JAK2 | Homo sapiens (Human) | EV |
P42679 | MATK | Megakaryocyte-associated tyrosine-protein kinase | Homo sapiens (Human) | SS |
P52333 | JAK3 | Tyrosine-protein kinase JAK3 | Homo sapiens (Human) | SS |
Q08881 | ITK | Tyrosine-protein kinase ITK/TSK | Homo sapiens (Human) | EV |
P07948 | LYN | Tyrosine-protein kinase Lyn | Homo sapiens (Human) | SS |
P29597 | TYK2 | Non-receptor tyrosine-protein kinase TYK2 | Homo sapiens (Human) | EV |
Q13882 | PTK6 | Protein-tyrosine kinase 6 | Homo sapiens (Human) | EV |
P08631 | HCK | Tyrosine-protein kinase HCK | Homo sapiens (Human) | EV |
P07947 | YES1 | Tyrosine-protein kinase Yes | Homo sapiens (Human) | SS |
P42685 | FRK | Tyrosine-protein kinase FRK | Homo sapiens (Human) | EV |
Q06187 | BTK | Tyrosine-protein kinase BTK | Homo sapiens (Human) | EV |
Q9R117 | Tyk2 | Non-receptor tyrosine-protein kinase TYK2 | Mus musculus (Mouse) | SS |
Q62137 | Jak3 | Tyrosine-protein kinase JAK3 | Mus musculus (Mouse) | SS |
Q62120 | Jak2 | Tyrosine-protein kinase JAK2 | Mus musculus (Mouse) | EV |
P52332 | Jak1 | Tyrosine-protein kinase JAK1 | Mus musculus (Mouse) | SS |
P05480 | Src | Proto-oncogene tyrosine-protein kinase Src | Mus musculus (Mouse) | EV |
P06240 | Lck | Proto-oncogene tyrosine-protein kinase LCK | Mus musculus (Mouse) | SS |
P14234 | Fgr | Tyrosine-protein kinase Fgr | Mus musculus (Mouse) | SS |
P16277 | Blk | Tyrosine-protein kinase Blk | Mus musculus (Mouse) | SS |
P41241 | Csk | Tyrosine-protein kinase CSK | Mus musculus (Mouse) | EV |
Q03526 | Itk | Tyrosine-protein kinase ITK/TSK | Mus musculus (Mouse) | SS |
Q04736 | Yes1 | Tyrosine-protein kinase Yes | Mus musculus (Mouse) | SS |
Q64434 | Ptk6 | Protein-tyrosine kinase 6 | Mus musculus (Mouse) | SS |
Q922K9 | Frk | Tyrosine-protein kinase FRK | Mus musculus (Mouse) | SS |
P48025 | Syk | Tyrosine-protein kinase SYK | Mus musculus (Mouse) | SS |
P43404 | Zap70 | Tyrosine-protein kinase ZAP-70 | Mus musculus (Mouse) | SS |
P25911 | Lyn | Tyrosine-protein kinase Lyn | Mus musculus (Mouse) | EV |
P39688 | Fyn | Tyrosine-protein kinase Fyn | Mus musculus (Mouse) | SS |
P08103 | Hck | Tyrosine-protein kinase HCK | Mus musculus (Mouse) | SS |
P24604 | Tec | Tyrosine-protein kinase Tec | Mus musculus (Mouse) | SS |
P41242 | Matk | Megakaryocyte-associated tyrosine-protein kinase | Mus musculus (Mouse) | SS |
Q9QVP9 | Ptk2b | Protein-tyrosine kinase 2-beta | Mus musculus (Mouse) | PR |
P34152 | Ptk2 | Focal adhesion kinase 1 | Mus musculus (Mouse) | SS |
Q99ML2 | Tnk1 | Non-receptor tyrosine-protein kinase TNK1 | Mus musculus (Mouse) | PR |
O54967 | Tnk2 | Activated CDC42 kinase 1 | Mus musculus (Mouse) | SS |
P70451 | Fer | Tyrosine-protein kinase Fer | Mus musculus (Mouse) | PR |
Q6J9G1 | Styk1 | Tyrosine-protein kinase STYK1 | Mus musculus (Mouse) | PR |
P00520 | Abl1 | Tyrosine-protein kinase ABL1 | Mus musculus (Mouse) | EV |
Q62270 | Srms | Tyrosine-protein kinase Srms | Mus musculus (Mouse) | SS |
Q4JIM5 | Abl2 | Tyrosine-protein kinase ABL2 | Mus musculus (Mouse) | SS |
A1Y2K1 | FYN | Tyrosine-protein kinase Fyn | Sus scrofa (Pig) | SS |
O19064 | JAK2 | Tyrosine-protein kinase JAK2 | Sus scrofa (Pig) | SS |
Q62662 | Frk | Tyrosine-protein kinase FRK | Rattus norvegicus (Rat) | SS |
Q62844 | Fyn | Tyrosine-protein kinase Fyn | Rattus norvegicus (Rat) | SS |
Q07014 | Lyn | Tyrosine-protein kinase Lyn | Rattus norvegicus (Rat) | SS |
P50545 | Hck | Tyrosine-protein kinase HCK | Rattus norvegicus (Rat) | SS |
Q9WUD9 | Src | Proto-oncogene tyrosine-protein kinase Src | Rattus norvegicus (Rat) | SS |
Q01621 | Lck | Proto-oncogene tyrosine-protein kinase LCK | Rattus norvegicus (Rat) | SS |
Q6P6U0 | Fgr | Tyrosine-protein kinase Fgr | Rattus norvegicus (Rat) | SS |
Q62689 | Jak2 | Tyrosine-protein kinase JAK2 | Rattus norvegicus (Rat) | SS |
Q63272 | Jak3 | Tyrosine-protein kinase JAK3 | Rattus norvegicus (Rat) | SS |
P32577 | Csk | Tyrosine-protein kinase CSK | Rattus norvegicus (Rat) | SS |
P41243 | Matk | Megakaryocyte-associated tyrosine-protein kinase | Rattus norvegicus (Rat) | SS |
F1LM93 | Yes1 | Tyrosine-protein kinase Yes | Rattus norvegicus (Rat) | SS |
O45539 | src-2 | Tyrosine protein-kinase src-2 | Caenorhabditis elegans | SS |
G5ECJ6 | csk-1 | Tyrosine-protein kinase csk-1 | Caenorhabditis elegans | SS |
G5EE56 | src-1 | Tyrosine protein-kinase src-1 | Caenorhabditis elegans | SS |
A1A5H8 | yes1 | Tyrosine-protein kinase yes | Danio rerio (Zebrafish) (Brachydanio rerio) | SS |
F1RDG9 | fynb | Tyrosine-protein kinase fynb | Danio rerio (Zebrafish) (Brachydanio rerio) | SS |
O12990 | jak1 | Tyrosine-protein kinase JAK1 | Danio rerio (Zebrafish) (Brachydanio rerio) | PR |
Q1JPZ3 | src | Proto-oncogene tyrosine-protein kinase Src | Danio rerio (Zebrafish) (Brachydanio rerio) | SS |
Q6EWH2 | fyna | Tyrosine-protein kinase fyna | Danio rerio (Zebrafish) (Brachydanio rerio) | SS |
10 | 20 | 30 | 40 | 50 | 60 |
MAAVILESIF | LKRSQQKKKT | SPLNFKKRLF | LLTVHKLSYY | EYDFERGRRG | SKKGSIDVEK |
70 | 80 | 90 | 100 | 110 | 120 |
ITCVETVIPE | KNPPPERQIP | RRGEESSEME | QISIIERFPY | PFQVVYDEGP | LYVFSPTEEL |
130 | 140 | 150 | 160 | 170 | 180 |
RKRWIHQLKN | VIRYNSDLVQ | KYHPCFWIDG | QYLCCSQTAK | NAMGCQILEN | RNGSLKPGSS |
190 | 200 | 210 | 220 | 230 | 240 |
HRKTKKPLPP | TPEEDQILKK | PLPPEPTAAP | ISTTELKKVV | ALYDYMPMNA | NDLQLRKGEE |
250 | 260 | 270 | 280 | 290 | 300 |
YFILEESNLP | WWRARDKNGQ | EGYIPSNYIT | EAEDSIEMYE | WYSKHMTRSQ | AEQLLKQEGK |
310 | 320 | 330 | 340 | 350 | 360 |
EGGFIVRDSS | KAGKYTVSVF | AKSTGEPQGV | IRHYVVCSTP | QSQYYLAEKH | LFSTIPELIN |
370 | 380 | 390 | 400 | 410 | 420 |
YHQHNSAGLI | SRLKYPVSKQ | NKNAPSTAGL | GYGSWEIDPK | DLTFLKELGT | GQFGVVKYGK |
430 | 440 | 450 | 460 | 470 | 480 |
WRGQYDVAIK | MIREGSMSED | EFIEEAKVMM | NLSHEKLVQL | YGVCTKQRPI | FIITEYMANG |
490 | 500 | 510 | 520 | 530 | 540 |
CLLNYLREMR | HRFQTQQLLE | MCKDVCEAME | YLESKQFLHR | DLAARNCLVN | DQGVVKVSDF |
550 | 560 | 570 | 580 | 590 | 600 |
GLSRYVLDDE | YTSSVGSKFP | VRWSPPEVLM | YSKFSSKSDI | WAFGVLMWEI | YSLGKMPYER |
610 | 620 | 630 | 640 | 650 | |
FTNSETAEHI | AQGLRLYRPH | LASERVYTIM | YSCWHEKADE | RPSFKILLSN | ILDVMDEES |